Literature DB >> 7754645

Observation of gastric glandular cysts in the corpus mucosa of the stomach under omeprazole treatment.

M Stolte1, B Bethke, E Seifert, U Armbrecht, A Lütke, P Goldbrunner, U Rabast.   

Abstract

In patients undergoing long-term treatment with omeprazole, tiny gastric polyps, described histologically as glandular cysts, have occasionally been reported. We report on a further nine patients (5 women and 4 men) undergoing omeprazole treatment who developed endoscopically visible and histologically verified glandular cysts. Eight patients were on long-term treatment with omeprazole for reflux oesophagitis, and the glandular cysts were observed between 8 and 60 months after the start of treatment. In one patient with an NSAID-induced ulcer, a tiny polyp was found only three weeks after initiation of treatment. None of the patients had Helicobacter pylori-associated gastritis. The cysts, which measured between 0.25 and 0.7 mm in diameter, were mostly lined with flattened parietal and chief cells, but in three cases also with foveolar epithelium, so that they could not be reliably distinguished from Elster's gastric glandular cysts. These glandular cysts are harmless, and do not require further diagnostic or therapeutic measures. They probably develop spontaneously independently of the omeprazole therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7754645

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  10 in total

Review 1.  Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies.

Authors:  Jeong Soo Ahn; Chun-Sick Eom; Christie Y Jeon; Sang Min Park
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

Review 2.  Adverse effects of long-term proton pump inhibitor therapy.

Authors:  Edward Sheen; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-03-02       Impact factor: 3.199

3.  Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.

Authors:  Hajime Anjiki; Ken-Ichi Mukaisho; Yu Kadomoto; Hisakazu Doi; Kunio Yoshikawa; Takahisa Nakayama; Diem Thi-Ngoc Vo; Takanori Hattori; Hiroyuki Sugihara
Journal:  Clin J Gastroenterol       Date:  2017-02-03

4.  Chief cell proliferation of the gastric mucosa mimicking early gastric cancer: an unusual variant of fundic gland polyp.

Authors:  J Müller-Höcker; P Rellecke
Journal:  Virchows Arch       Date:  2003-04-16       Impact factor: 4.064

Review 5.  Development of white globe appearance lesions in the noncancerous stomach after vonoprazan administration: a report of two cases with a literature review.

Authors:  Wataru Miwa; Takashi Hiratsuka; Ken Sato; Takashi Fujino; Yo Kato
Journal:  Clin J Gastroenterol       Date:  2020-10-06

Review 6.  Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.

Authors:  H D Langtry; M I Wilde
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546

7.  Rebamipide contributes to reducing adverse effects of long-term administration of omeprazole in rats.

Authors:  Tadashi Hagiwara; Ken-ichi Mukaisho; Zhi-Qiang Ling; Takayo Sakano; Hiroyuki Sugihara; Takanori Hattori
Journal:  Dig Dis Sci       Date:  2007-03-07       Impact factor: 3.199

8.  Development of pancreatic acinar cell metaplasia after successful administration of omeprazole for 6 months in rats.

Authors:  Tadashi Hagiwara; Ken-ichi Mukaisho; Zhi-Qiang Ling; Hiroyuki Sugihara; Takanori Hattori
Journal:  Dig Dis Sci       Date:  2007-03-15       Impact factor: 3.487

9.  Management of hyperplastic gastric polyp following upper gastrointestinal bleeding in infant with Menkes' disease.

Authors:  Dalia Belsha; Priya Narula; Arun Urs; Mike Thomson
Journal:  World J Gastrointest Endosc       Date:  2017-07-16

10.  Are gastric hyperplastic polyps an additional manifestation in celiac disease?: Results from a retrospective study.

Authors:  Maria Pina Dore; Giovanni Mario Pes; Chiara Rocchi; Maria Francesca Loria; Sara Soro; Gabrio Bassotti
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.